Clinical trial
A Study of E3810 With Pre- and Post-Treatment pH Monitoring in Patients With…
NCT00165672 · Eisai Inc., Industry · Completed
Key facts
| NCT number | NCT00165672 |
|---|---|
| Title | A Study of E3810 With Pre- and Post-Treatment pH Monitoring in Patients With Non-Erosive Gastroesophageal Reflux Disease |
| Official title | A Clinical Pharmacology Study of E3810 With Pre- and Post-Treatment pH Monitoring in Patients With Non-Erosive Gastroesophageal Reflux Disease |
| Lead sponsor | Eisai Inc., Industry |
| Collaborators | Eisai Limited Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Non-erosive Gastroesophageal Reflux Disease |
| Intervention type | Drug |
| Interventions | RABEPRAZOLE SODIUM |
| Enrollment | 26 |
| Start date | May 1, 2005 |
| Primary completion | Oct 1, 2005 |
| Completion | Oct 1, 2005 |
| First posted | Sep 14, 2005 |
| Last update posted | Oct 5, 2011 |
| Countries | Japan |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: